Clinical Trials
2 trialsNCT07030140 2026-05-01
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT05024513 2025-12-18
Biliary Drainage Plus HAIC in Locally Advanced pCCA
Peking University
Phase 2 Completed